XASX
GLH
Market cap3mUSD
Dec 05, Last price
0.09AUD
1D
2.27%
1Q
-18.18%
Jan 2017
-79.17%
IPO
-98.88%
Name
Global Health Ltd
Chart & Performance
P/E
—
P/S
0.61
EPS
—
Div Yield, %
—
Shrs. gr., 5y
10.67%
Rev. gr., 5y
8.06%
Revenues
9m
+10.76%
Net income
-1m
L-83.71%
CFO
-1m
L-67.28%
Dividend
Mar 01, 20170.01 AUD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Global Health Limited provides digital health solutions for the healthcare sector in Australia. It provides mental health software for psychologists and psychiatrists; and integrated software solutions for various areas of community health and human services, including drug and alcohol, disability, post-acute care, community care, mental health services, and community rehabilitation, as well as offers software solutions for home care and aged care, consumer engagement tools, general practice, and pharmacy. The company's products include MasterCare EMR, an Electronic Medical Record; MasterCare + that helps organizations in digitizing their services and processes; MasterCare PAS, a patient administration system; PrimaryClinic, a medical and practice management software for general practitioners and specialists that share the same patient demographic. It also provides ReferralNet to send and receive various document types; LifeCard, a personal health record; and HotHealth, a digital engagement tool. In addition, the company offers MasterCare Data Warehouse that removes the need for spreadsheets, exports, and time-consuming analysis; e-switch, a middleware software to exchange data externally, internally, and between different software systems; Patient Portal, an online portal to capture patient data digitally via an online form prior to admission; and Altitude, a cloud hosting service. Global Health Limited was founded in 1985 and is headquartered in Melbourne, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||